Literature DB >> 11204517

Biosurgery in wound healing--the renaissance of maggot therapy.

U Wollina1, K Karte, C Herold, A Looks.   

Abstract

Chronic wounds are a challenge for modern health care. A basic principle of treatment is the removal of sloughy, necrotic, devitalized tissue to prevent wound infection and delayed healing. Biosurgery (syn. maggot or larval therapy) is a promising adjunct to the whole spectrum of topical treatment methods, in particular for debridement. The term 'biosurgery' describes the use of living maggots on wounds to remove devitalized tissue, decrease the risk of infection and improve wound healing. The present paper gives a brief review of history, entomology, biochemistry and medical indications of biosurgery and the practical handling of maggots. We also provide some clinical data from the literature and our own experience in a wound care unit. Biosurgery is an effective and safe treatment option for debridement and disinfection.

Entities:  

Mesh:

Year:  2000        PMID: 11204517     DOI: 10.1046/j.1468-3083.2000.00105.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

Review 1.  [Established and current procedures in wound healing].

Authors:  D Dill-Müller; W Tilgen
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

Review 2.  Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential.

Authors:  Iain S Whitaker; Christopher Twine; Michael J Whitaker; Mathew Welck; Charles S Brown; Ahmed Shandall
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

3.  Lucilia sericata chymotrypsin disrupts protein adhesin-mediated staphylococcal biofilm formation.

Authors:  Llinos G Harris; Yamni Nigam; James Sawyer; Dietrich Mack; David I Pritchard
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

4.  Massive scalp myiasis with bleeding in a patient with multiple malignancies.

Authors:  Uwe Wollina
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

5.  Clinical study of Maggot therapy for Fournier's gangrene.

Authors:  Alicia Fonseca-Muñoz; Hugo E Sarmiento-Jiménez; Rafael Pérez-Pacheco; Patricia J Thyssen; Ronald A Sherman
Journal:  Int Wound J       Date:  2020-07-21       Impact factor: 3.315

Review 6.  Myiasis on squamous cell carcinoma of skin.

Authors:  Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-11-12

7.  Maggot debridement therapy for peripheral arterial disease.

Authors:  Kimihiro Igari; Takahiro Toyofuku; Hidetoshi Uchiyama; Shinya Koizumi; Koji Yonekura; Toshifumi Kudo; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2013-05-30

8.  Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds.

Authors:  Pascal Steenvoorde; Cathrien E Jacobi; Louk Van Doorn; Jacques Oskam
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

9.  Pansclerotic morphea in childhood: a case report.

Authors:  T Doede; U Wollina; W Hindermann; F Schier; M Bondartschuk
Journal:  Pediatr Surg Int       Date:  2003-06-21       Impact factor: 1.827

Review 10.  [Future treatment options for chronic wounds].

Authors:  L Steinsträsser; R Hasler; T Hirsch; A Daigeler; S Langer; H U Steinau
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.